OKYO Historical Financial Ratios
| OKYO Stock | USD 1.06 0.01 0.93% |
OKYO Pharma is promptly reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 314.8 K will help investors to properly organize and evaluate OKYO Pharma financial condition quickly.
OKYO |
About OKYO Financial Ratios Analysis
OKYO PharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate OKYO Pharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on OKYO financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across OKYO Pharma history.
OKYO Pharma Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is OKYO Pharma Ltd dividend as a percentage of OKYO Pharma stock price. OKYO Pharma dividend yield is a measure of OKYO Pharma stock productivity, which can be interpreted as interest rate earned on an OKYO Pharma investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to OKYO Pharma Ltd. There are two different methods for calculating OKYO Pharma invested capital: operating approach and financing approach. Understanding OKYO Pharma invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Most ratios from OKYO Pharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into OKYO Pharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. At this time, OKYO Pharma's Average Payables is very stable compared to the past year. Capex To Operating Cash Flow is expected to grow at the current pace this year, while PTB Ratio is likely to drop (7.70).
| 2023 | 2024 (projected) | Net Current Asset Value | 42.89 | 38.12 | Days Payables Outstanding | 213.7K | 194.5K |
OKYO Pharma fundamentals Correlations
Click cells to compare fundamentals
OKYO Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OKYO Pharma fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | (15.4K) | 457.84 | 1.2K | (18.21) | (7.34) | (7.7) | |
| Book Value Per Share | (2.35E-4) | 0.007907 | 0.00301 | (0.0923) | (0.2) | (0.19) | |
| Free Cash Flow Yield | (0.00107) | (5.58E-4) | (6.6E-4) | (0.001543) | (0.21) | (0.22) | |
| Operating Cash Flow Per Share | (0.002019) | (0.002379) | (0.005584) | (0.35) | (0.32) | (0.31) | |
| Pb Ratio | (15.4K) | 457.84 | 1.2K | (18.21) | (7.34) | (7.7) | |
| Free Cash Flow Per Share | (0.002019) | (0.002389) | (0.005586) | (0.35) | (0.32) | (0.31) | |
| Roic | 10.35 | (0.77) | (1.84) | 51.13 | 0.002682 | 0.002548 | |
| Net Income Per Share | (0.00259) | (0.004985) | (0.005546) | (0.6) | (5.73E-4) | (6.02E-4) | |
| Payables Turnover | 0.0124 | 0.062 | 0.004681 | 0.003709 | 0.001708 | 0.001623 | |
| Average Inventory | (333.08) | (379.04) | (728.5) | (745.5) | (857.32) | (900.19) | |
| Cash Per Share | 3.95E-4 | 0.0102 | 0.002758 | 0.18 | 0.0282 | 0.0268 | |
| Pocfratio | (1.8K) | (1.5K) | (648.26) | (4.86) | (4.55) | (4.77) | |
| Pfcf Ratio | (1.8K) | (1.5K) | (648.07) | (4.86) | (4.55) | (4.77) | |
| Days Payables Outstanding | 29.3K | 5.9K | 78.0K | 98.4K | 213.7K | 194.5K | |
| Income Quality | 0.41 | 0.74 | 0.47 | 0.88 | 0.58 | 0.56 | |
| Roe | 11.03 | (0.63) | (1.84) | 6.46 | 0.002862 | 0.003005 | |
| Ev To Operating Cash Flow | (1.8K) | (1.5K) | (647.77) | (4.62) | (4.46) | (4.68) | |
| Pe Ratio | (1.4K) | (726.23) | (652.68) | (2.82) | (2.6K) | (2.4K) | |
| Return On Tangible Assets | (2.58) | (0.47) | (1.26) | (2.55) | (0.0109) | (0.0115) | |
| Ev To Free Cash Flow | (1.8K) | (1.5K) | (647.57) | (4.62) | (4.46) | (4.68) | |
| Earnings Yield | (7.15E-4) | (0.001377) | (0.001532) | (0.35) | (3.9E-4) | (4.1E-4) | |
| Current Ratio | 0.8 | 4.09 | 3.17 | 0.72 | 0.21 | 0.2 | |
| Tangible Book Value Per Share | (2.35E-4) | 0.007907 | 0.00301 | (0.0923) | (0.2) | (0.19) | |
| Graham Number | 0.003699 | 0.0298 | 0.0194 | 1.11 | 0.0508 | 0.0483 | |
| Shareholders Equity Per Share | (2.35E-4) | 0.007907 | 0.00301 | (0.0923) | (0.2) | (0.19) | |
| Graham Net Net | (4.33E-4) | 0.007607 | 0.001375 | (0.14) | (0.21) | (0.2) | |
| Enterprise Value Over E B I T D A | (1.4K) | (724.29) | (569.9) | (2.7) | (2.7K) | (2.6K) | |
| Price Earnings Ratio | (1.4K) | (726.23) | (652.68) | (2.82) | (2.6K) | (2.4K) | |
| Price Book Value Ratio | (15.4K) | 457.84 | 1.2K | (18.21) | (7.34) | (7.7) |
Pair Trading with OKYO Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OKYO Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against OKYO Stock
| 0.38 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to OKYO Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OKYO Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OKYO Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OKYO Pharma Ltd to buy it.
The correlation of OKYO Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OKYO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OKYO Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OKYO Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (2.92) | Return On Equity (29.69) |
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.